Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: Implications for kinase function and disease pathogenesis

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 10, 2003, Pages 1251-1255

  Oliveira, Sandra Marisa J ^a   Ehtisham, Javed ^a   Redwood, Charles S ^a   Ostman Smith, Ingegerd ^a   Blair, Edward M ^a   Watkins, Hugh ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

AMPK; Cardiomyopathy; Mutation; Wolff Parkinson White

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN KINASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CARDIOMYOPATHY; CATALYSIS; CATALYST; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; GENETIC CODE; GENETIC POLYMORPHISM; HEART MUSCLE; HUMAN; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; SCREENING TEST;

EID: 0141569397     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00237-2     Document Type: Article

References (27)

1. Seidman J.G., Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 104:2001;557-567.
2. Richard P., Charron P., Carrier L., Ledeuil C., Cheav T., Pichereau C., et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 107:2003;2227-2232.
3. Ashrafian H., Redwood C., Blair E., Watkins H. Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trend Genet. 19:2003;263-268.
4. Merante F., Tein I., Benson L., Robinson B.H. Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA (glycine) gene. Am J Hum Genet. 55:1994;437-446.
5. Puccio H., Koenig M. Recent advances in the molecular pathogenesis of Friedreich ataxia. Hum Mol Genet. 9:2000;887-892.
6. Tanaka T., Sohmiya K., Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol. 29:1997;121-127.
7. Aoyama T., Souri M., Ushikubo S., Kamijo T., Yamaguchi S., Kelley R.I., et al. Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. J Clin Invest. 95:1995;2465-2473.
8. MacRae C.A., Ghaisas N., Kass S., Donnelly S., Basson C.T., Watkins H.C., et al. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest. 96:1995;1216-1220.
9. Lang T., Yu L., Tu Q., Jiang J., Chen Z., Xin Y., et al. Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5′-AMP-activated protein kinase, to human chromosome 7q36. Genomics. 70:2000;258-263.
10. Blair E., Redwood C., Ashrafian H., Oliveira M., Broxholme J., Kerr B., et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet. 10:2001;1215-1220.
11. Gollob M.H., Green M.S., Tang A.S., Gollob T., Karibe A., Ali Hassan A.S., et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. New Engl J M. 344:2001;1823-1831.
12. Gollob M.H., Seger J.J., Gollob T.N., Tapscott T., Gonzales O., Bachinski L., et al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation. 104:2001;3030-3033.
13. Arad M., Benson D.W., Perez-Atayde A.R., McKenna W.J., Sparks E.A., Kanter R.J., et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest. 109:2002;357-362.
14. Hardie D.G., Carling D. The AMP-activated protein kinase: fuel gauge of the mammalian cell? Eur J Biochem. 246:1997;259-273.
15. Hardie D.G., Hawley S.A. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays. 23:2001;1112-1119.
16. Hudson E.R., Pan D.A., James J., Lucocq J.M., Hawley S.A., Green K.A., et al. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr Biol. 13:2003;861-866.
17. Polekhina G., Gupta A., Michell B.J., van Denderen B., Murthy S., Feil S.C., et al. AMPK beta subunit targets metabolic stress sensing to glycogen. Curr Biol. 13:2003;867-871.
18. Cheung P.C., Salt I.P., Davies S.P., Hardie D.G., Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J. 346:2000;659-669.
19. Bateman A. The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trend Biochem Sci. 22:1997;12-13.
20. Janosik M., Kery V., Gaustadnes M., Maclean K.N., Kraus J.P. Regulation of human cystathionine beta-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry. 40:2001;10625-10633.
21. Don R.H., Cox P.T., Wainwright B.J., Baker K., Mattick J.S. "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19:1991;4008.
22. Vaughan C.J., Hom Y., Okin D.A., McDermott D.A., Lerman B.B., Basson C.T. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol. 14:2003;263-268.
23. Daniel T., Carling D. Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J Biol Chem. 277:2002;51017-51024.
24. Carlson M. Glucose repression in yeast. Curr Opin Microbiol. 2:1999;202-207.
25. Hamilton S.R., Stapleton D., O'Donnell J.B. Jr, Kung J.T., Dalal S.R., Kemp B.E., et al. An activating mutation in the gamma1 subunit of the AMP-activated protein kinase. FEBS Lett. 500:2001;163-168.
26. Milan D., Jeon J.T., Looft C., Amarger V., Robic A., Thelander M., et al. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science. 288:2000;1248-1251.
27. Zhang R., Evans G., Rotella F., Westbrook E., Beno D., Huberman Eliezer, et al. Characteristics and crystal structure of bacterial inosine-5′ -monophosphate dehydrogenase. Biochemistry. 38:1999;4691-4700.